SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

Section 7.2   Conditions to Obligations of the Sellers 75
Section 7.3   Conditions to Obligations of the Buyer 76
Article VIII TERMINATION
Section 8.1   Termination 77
Section 8.2   Effect of Termination 79
Section 8.3   Expense Reimbursement Amount 79
Article IX GENERAL PROVISIONS
Section 9.1   Nonsurvival of Representations, Warranties and Covenants 80
Section 9.2   Fees and Expenses 81
Section 9.3   Transition of Permits 81
Section 9.4   Amendment and Modification 81
Section 9.5   Waiver 81
Section 9.6   Notices 81
Section 9.7   Interpretation 83
Section 9.8   Entire Agreement 83
Section 9.9   Parties in Interest 84
Section 9.10   Governing Law 84
Section 9.11   Submission to Jurisdiction 84
Section 9.12   Disclosure Generally 85
Section 9.13   Personal Liability; Non-recourse 85
Section 9.14   Assignment; Successors 85
Section 9.15   Enforcement 86
Section 9.16   Currency 86
Section 9.17   Severability 86
Section 9.18   Waiver of Jury Trial 86
Section 9.19   Counterparts 87
Section 9.20   Facsimile or .pdf Signature 87
Section 9.21   Time of Essence 87
Section 9.22   Damages Limitation 87
Section 9.23   Bulk Sales 87
Section 9.24   No Presumption Against Drafting Party 87
Section 9.25   Conflicts; Privileges 87

   

 

Annex A Sellers
Exhibit 1 [RESERVED]
Exhibit 2 [RESERVED]
Exhibit 3 Form of Sale Order
Exhibit 4 Form of Sale Procedures Order
Exhibit 5 Form of Bill of Sale
Exhibit 6 Form of IP Assignment Agreement
Exhibit 7 Form of IP License Agreement